Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products

Joseph V. Pergolizzi, Christopher G. Gharibo, Jeffrey A. Gudin, Srinivas R. Nalamachu

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalPain Practice
Volume13
Issue number4
DOIs
StatePublished - Apr 2013

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this